A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus
3 other identifiers
interventional
268
19 countries
147
Brief Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE). The extension period will provide additional long-term safety and efficacy data and enable those participants initially randomized to placebo to receive treatment with Afimetoran.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2021
Longer than P75 for phase_2
147 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2021
CompletedFirst Posted
Study publicly available on registry
May 20, 2021
CompletedStudy Start
First participant enrolled
October 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2029
ExpectedJune 10, 2025
June 1, 2025
4.5 years
May 19, 2021
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of participants that achieve an SLE (Systemic Lupus Erythematosus) Responder Index (4) (SRI(4)) response at Week 48
Up to 48 Weeks
Secondary Outcomes (16)
Proportion of participants that achieve a British Isles Lupus Assessment Group (BILAG)-based Combine Lupus Assessment (BICLA) response at Week 24 and Week 48
Up to 48 Weeks
Proportion of participants who achieve an SRI(4) response at Week 24
Up to 24 Weeks
Proportion of participants who achieve a Lupus Low Disease Activity State (LLDAS) response at Week 24 and Week 48
Up to 48 Weeks
Proportion of participants with a Cutaneous Lupus Erythematosus Disease Area and Severity Index; Activity (CLASI-A) score ≥ 10 at baseline who achieve a decrease of ≥ 50% from baseline CLASI-A score (CLASI-50) response at Week 24 and Week 48
Up to 48 Weeks
Proportion of participants with 6 or more swollen joints and 6 or more tender joints at baseline who achieve a ≥ 50% reduction from baseline in both swollen and tender joints at Week 24 and Week 48
Up to 48 Weeks
- +11 more secondary outcomes
Study Arms (4)
Afimetoran: Dose 1
EXPERIMENTALAfimetoran: Dose 2
EXPERIMENTALAfimetoran: Dose 3
EXPERIMENTALPlacebo
PLACEBO COMPARATORInterventions
Specified dose on specified days
Eligibility Criteria
You may qualify if:
- Diagnosed ≥ 12 weeks before the screening visit and qualify as having SLE according to the SLE International Collaborating Clinics (SLICC) Classification Criteria at the screening visit
- Test positive, as determined by the central laboratory, for at least one of the following lupus related autoantibodies at the time of screening: antinuclear antibody ≥ 1:80, anti-double-stranded deoxyribonucleic acid (dsDNA) antibody, or anti-Smith antibody.
- Have a total Hybrid Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score ≥ 6 points and clinical Hybrid SLEDAI score ≥ 4 points with joint involvement and/or rash
You may not qualify if:
- Active severe lupus nephritis (LN) as assessed by the investigator
- Active or unstable neuropsychiatric lupus manifestations defined by the Hybrid SLEDAI
- Diagnosis of Mixed Connective Tissue Disease for which the predominant diagnosis is not SLE
- Antiphospholipid Syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (147)
Local Institution - 0100
Birmingham, Alabama, 35205, United States
Local Institution - 0123
Huntington Beach, California, 92648, United States
Local Institution - 0170
La Jolla, California, 92037, United States
Local Institution - 0159
La Palma, California, 90623, United States
Local Institution - 0172
San Diego, California, 92128, United States
Local Institution - 0164
Woodland Hills, California, 91364, United States
Local Institution - 0121
Clearwater, Florida, 33765, United States
Local Institution - 0167
Kissimmee, Florida, 34741, United States
Local Institution - 0122
Orlando, Florida, 32808, United States
Local Institution - 0173
Ormond Beach, Florida, 32174, United States
Local Institution - 0154
Plantation, Florida, 33324, United States
Local Institution - 0137
South Miami, Florida, 33143, United States
Local Institution - 0155
Tamarac, Florida, 33321, United States
Local Institution - 0160
Atlanta, Georgia, 30318, United States
Local Institution - 0205
Suwanee, Georgia, 30024, United States
Local Institution - 0146
Orland Park, Illinois, 60467, United States
Local Institution - 0187
Hopkinsville, Kentucky, 42240, United States
Local Institution - 0171
Baton Rouge, Louisiana, 70836, United States
Local Institution - 0134
Wheaton, Maryland, 20902, United States
Local Institution - 0070
Eagan, Minnesota, 55121, United States
Local Institution - 0124
St Louis, Missouri, 63110, United States
Local Institution - 0165
St Louis, Missouri, 63141, United States
Local Institution - 0091
Las Vegas, Nevada, 89128, United States
Local Institution - 0219
West Long Branch, New Jersey, 07764, United States
Local Institution - 0140
Manhasset, New York, 11030, United States
Local Institution - 0132
The Bronx, New York, 10461, United States
Local Institution - 0203
Charlotte, North Carolina, 28204, United States
Local Institution - 0103
Charlotte, North Carolina, 28211, United States
Local Institution - 0151
Columbus, Ohio, 43203, United States
Local Institution - 0042
Middleburg Heights, Ohio, 44130, United States
Local Institution - 0152
Allen, Texas, 75013, United States
Local Institution - 0197
Allen, Texas, 75013, United States
Local Institution - 0136
Amarillo, Texas, 79124, United States
Local Institution - 0029
Mesquite, Texas, 75150, United States
Local Institution - 0163
San Antonio, Texas, 78215, United States
Local Institution - 0223
Bellevue, Washington, 98004, United States
Local Institution - 0130
Quilmes, Buenos Aires, 1878, Argentina
Local Institution - 0195
San Fernando, Buenos Aires, 1646, Argentina
Local Institution - 0025
Córdoba, Córdoba Province, 5004, Argentina
Local Institution - 0074
Buenos Aires, Distrito Federal, C1121ABE, Argentina
Local Institution - 0040
CABA, Distrito Federal, 1406, Argentina
Local Institution - 0027
San Miguel de Tucumán, Tucumán Province, T4000, Argentina
Local Institution - 0207
Buenos Aires, 1425, Argentina
Local Institution - 0128
Buenos Aires, C1426ABP, Argentina
Local Institution - 0041
San Juan, 5400, Argentina
Local Institution - 0063
Botany, New South Wales, 2019, Australia
Local Institution - 0072
Westmead, New South Wales, 2145, Australia
Local Institution - 0066
Maroochydore, Queensland, 4558, Australia
Local Institution - 0065
Woodville, South Australia, 5011, Australia
Local Institution - 0062
Camberwell, Victoria, 3124, Australia
Local Institution - 0064
Ivanhoe, Victoria, 3079, Australia
Local Institution - 0006
Salvador, Estado de Bahia, 40150-150, Brazil
Local Institution - 0031
Salvador, Estado de Bahia, 41820-020, Brazil
Local Institution - 0093
Cuiabá, Mato Grosso, 78020-500, Brazil
Local Institution - 0008
Juiz de Fora, Minas Gerais, 36010-570, Brazil
Local Institution - 0010
Curitiba, Paraná, 80030110, Brazil
Local Institution - 0007
Porto Alegre, Rio Grande do Sul, 90480-000, Brazil
Local Institution - 0014
São Bernardo do Campo, São Paulo, 09715-090, Brazil
Local Institution - 0045
São José do Rio Preto, São Paulo, 15090000, Brazil
Local Institution - 0009
São Paulo, 04266-010, Brazil
Local Institution - 0127
Osorno, Los Lagos Region, 5290000, Chile
Local Institution - 0143
Valdivia, Los Ríos Region, 2279374, Chile
Local Institution - 0075
Providencia, Santiago Metropolitan, 7500504, Chile
Local Institution - 0073
Santiago, Santiago Metropolitan, 0, Chile
Local Institution - 0043
Santiago, Santiago Metropolitan, 7501126, Chile
Local Institution - 0177
Beijing, Beijing Municipality, 100029, China
Local Institution - 0180
Beijing, Beijing Municipality, 100144, China
Local Institution - 0184
Shenzhen, Guangdong, 518107, China
Local Institution - 0176
Nanjing, Jiangsu, 210000, China
Local Institution - 0188
Nanjing, Jiangsu, 210029, China
Local Institution - 0193
Suzhou, Jiangsu, 215006, China
Local Institution - 0174
Changchun, Jilin, 130000, China
Local Institution - 0179
Dalian, Liaoning, 116023, China
Local Institution - 0178
Jinan, Shandong, 250012, China
Local Institution - 0183
Jining, Shandong, 272011, China
Local Institution - 0190
Medellín, Antioquia, 050021, Colombia
Local Institution - 0001
Barranquilla, 080020, Colombia
Local Institution - 0004
Bogotá, 110221, Colombia
Local Institution - 0076
Cali, 760042, Colombia
Local Institution - 0005
Chía, 250001, Colombia
Local Institution - 0003
Zipaquirá, 250252, Colombia
Local Institution - 0156
Pessac, Aquitaine, 33600, France
Local Institution - 0083
Brest, Finistère, 29609, France
Local Institution - 0048
Bordeaux, 33076, France
Local Institution - 0144
Caen, 14033, France
Local Institution - 0129
Lille, 59037, France
Local Institution - 0112
Marseille, 13003, France
Local Institution - 0044
Strasbourg, 67098, France
Local Institution - 0087
Cologne, North Rhine-Westphalia, 50937, Germany
Local Institution - 0085
Berlin, 10117, Germany
Local Institution - 0086
Essen, 45122, Germany
Local Institution - 0084
Freiburg im Breisgau, 79106, Germany
Local Institution - 0226
Ahmedabad, Gujarat, 380015, India
Local Institution - 0214
Gurugram, Haryana, 122001, India
Local Institution - 0210
Bengaluru, Karnataka, 560010, India
Local Institution - 0208
New Delhi, National Capital Territory of Delhi, 110029, India
Local Institution - 0209
Secunderabad, Telangana, 500003, India
Local Institution - 0119
Manorhamilton, Leitrim, 0, Ireland
Local Institution - 0106
Dublin, D15 X40D, Ireland
Local Institution - 0107
Galway, H91 TY80, Ireland
Local Institution - 0114
Eiheiji-cho,Yoshida-gun, Fukui, 910-1193, Japan
Local Institution - 0095
Kitakyushu, Fukuoka, 807-8556, Japan
Local Institution - 0096
Sapporo, Hokkaido, 060-8648, Japan
Local Institution - 0104
Kanazawa, Ishikawa-ken, 920-8641, Japan
Local Institution - 0099
Sendai, Miyagi, 980-8574, Japan
Local Institution - 0117
Bunkyo-ku, Tokyo, 1138431, Japan
Local Institution - 0218
Fuchū, Tokyo, 1838524, Japan
Local Institution - 0113
Itabashiku, Tokyo, 173-8610, Japan
Local Institution - 0150
Meguro-ku, Tokyo, 1538515, Japan
Local Institution - 0098
Shinjuku-ku, Tokyo, 1600035, Japan
Local Institution - 0105
Shinjuku-ku, Tokyo, 1628655, Japan
Local Institution - 0138
Aichi, 457-8511, Japan
Local Institution - 0115
Chiba, 260-8712, Japan
Local Institution - 0162
Fukushima, 960-1295, Japan
Local Institution - 0097
Tokyo, 104-8560, Japan
Local Institution - 0116
Tokyo, 113-8654, Japan
Local Institution - 0020
León, Guanajuato, 37000, Mexico
Local Institution - 0017
Guadalajara, Jalisco, 44650, Mexico
Local Institution - 0022
Zapopan, Jalisco, 45070, Mexico
Local Institution - 0060
Mexico City, Mexico City, 06760, Mexico
Local Institution - 0018
Mexico City, Mexico City, 11850, Mexico
Local Institution - 0071
Monterrey, Nuevo León, 64000, Mexico
Local Institution - 0021
Chihuahua City, 31210, Mexico
Local Institution - 0158
Mexico City, 14080, Mexico
Local Institution - 0061
Mérida, 97070, Mexico
Local Institution - 0204
Warsaw, Masovian Voivodeship, 02-665, Poland
Local Institution - 0049
Poznan, 60-218, Poland
Local Institution - 0149
Warsaw, 00-874, Poland
Local Institution - 0052
Wroclaw, 50-556, Poland
Local Institution - 0037
San Juan, 00917, Puerto Rico
Local Institution - 0082
Râmnicu Vâlcea, Vâlcea County, 247065, Romania
Local Institution - 0157
Bucharest, 011053, Romania
Local Institution - 0067
Bucharest, 011172, Romania
Local Institution - 0068
Giroc, 307220, Romania
Local Institution - 0206
Santander, Cantabria, 39008, Spain
Local Institution - 0056
A Coruña, 15006, Spain
Local Institution - 0058
Barcelona, 08035, Spain
Local Institution - 0055
Madrid, 28009, Spain
Local Institution - 0057
Seville, 41014, Spain
Local Institution - 0080
Kaohsiung Niao Sung Dist, 83301, Taiwan
Local Institution - 0081
Taichung, 404, Taiwan
Local Institution - 0078
Taichung, 407, Taiwan
Local Institution - 0079
Taipei, 10002, Taiwan
Local Institution - 0077
Taipei, 11217, Taiwan
Local Institution - 0111
Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
Local Institution - 0110
Bradford, BD5 0NA, United Kingdom
Local Institution - 0125
Manchester, M13 9WL, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2021
First Posted
May 20, 2021
Study Start
October 11, 2021
Primary Completion
March 29, 2026
Study Completion (Estimated)
April 22, 2029
Last Updated
June 10, 2025
Record last verified: 2025-06